DNMT1 and renal carcinoma: Interestingly, another DNMT1 inhibitor, 5‐aza‐2′‐deoxycytidine, failed to induce vacuolization in renal cancer cells and did not exhibit significant synergistic effects with everolimus (Figure S5, Supporting Information).